相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
Jocelyne Piret et al.
ANTIVIRAL RESEARCH (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Theresa Kaeuferle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review
Roy F. Chemaly et al.
ANTIVIRAL RESEARCH (2019)
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
Genovefa A. Papanicolaou et al.
CLINICAL INFECTIOUS DISEASES (2019)
Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System
Nayoun Kim et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2018)
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation
Aimee E. Hammerstrom et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
Nico Gagelmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
Sung-Yeon Cho et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Potential Beneficial effects of Cytomegalovirus infection after Transplantation
Nicolle H. R. Litjens et al.
FRONTIERS IN IMMUNOLOGY (2018)
Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation
Jan Styczynski
INFECTIOUS DISEASES AND THERAPY (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Current and future options for cytomegalovirus reactivation in hematopoietic cell transplantation patients
Johan Maertens et al.
FUTURE MICROBIOLOGY (2017)
Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review
Philip D. Bright et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients
Jiwon Jung et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort
Isobel D. Ramsay et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus
Xu-Ying Pei et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation
Michelle K. Yong et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
M. Neuenhahn et al.
LEUKEMIA (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies
Hwa Young Lee et al.
ONCOTARGET (2017)
Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study
Mindy G. Schuster et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options
Shigeo Fuji et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation
Justyna Ogonek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
Peter Lischka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers
Kiran Dole et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia
Ahmet H. Elmaagacli et al.
BLOOD (2016)
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer et al.
BLOOD (2016)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission
Jae-Ho Yoon et al.
ONCOTARGET (2016)
CMV-specific immune reconstitution following allogeneic stem cell transplantation
Emily Blyth et al.
VIRULENCE (2016)
Immunotherapy for opportunistic infections: Current status and future perspectives
Shigeo Fuji et al.
VIRULENCE (2016)
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
Margaret L. Green et al.
LANCET HAEMATOLOGY (2016)
Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation A Randomized Trial
Michael Boeckh et al.
ANNALS OF INTERNAL MEDICINE (2015)
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies
Michael Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
Miriam Ciaurriz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices
Veronique Erard et al.
CLINICAL INFECTIOUS DISEASES (2015)
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia
Ji Eun Jang et al.
ANNALS OF HEMATOLOGY (2015)
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation
Seung-Hwan Shin et al.
BLOOD RESEARCH (2015)
Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure
Thomas Goldner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation
Einat Shmueli et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Roy F. Chemaly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Martin Schmidt-Hieber et al.
BLOOD (2013)
Management of cytomegalovirus infection in haemopoietic stem cell transplantation
Vincent Emery et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Tae Hyang Lee et al.
BLOOD RESEARCH (2013)
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial
Larry R. Smith et al.
VACCINES (2013)
Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients
Martha T. van der Beek et al.
ANTIVIRAL THERAPY (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Risk Factors for Cytomegalovirus Retinitis in Patients with Cytomegalovirus Viremia after Hematopoietic Stem Cell Transplantation
Sohee Jeon et al.
OPHTHALMOLOGY (2012)
Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Daniele Lilleri et al.
PLOS ONE (2012)
Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
L. Krol et al.
BONE MARROW TRANSPLANTATION (2011)
Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
Karl S. Peggs et al.
CLINICAL INFECTIOUS DISEASES (2011)
Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects
Amar Safdar et al.
CLINICAL INFECTIOUS DISEASES (2011)
Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology
John R. Wingard et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Cytomegalovirus: pathogen, paradigm, and puzzle
Michael Boeckh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2011)
Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
Francisco M. Marty et al.
CURRENT OPINION IN VIROLOGY (2011)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update
Ruth Seggewiss et al.
BLOOD (2010)
Antiviral Drug Resistance of Human Cytomegalovirus
Nell S. Lurain et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation
Ann M. Leen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
Sebastien Hantz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus
Tiziano Allice et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin
S. H. Park et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Maribavir: A novel antiviral agent with activity against cytomegalovirus
Jennifer Trofe et al.
ANNALS OF PHARMACOTHERAPY (2008)
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J. Winston et al.
BLOOD (2008)
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Mary K. Wloch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
Thomas Widmann et al.
PLOS ONE (2008)
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet
W. Lawrence Drew et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants
SF Lacey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT
P Ljungman et al.
BONE MARROW TRANSPLANTATION (2004)
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
M Hakki et al.
BLOOD (2003)
In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses
SL Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
M Boeckh et al.
BLOOD (2003)
Suppressors of cytokine signalling (SOCS) in the immune system
WS Alexander
NATURE REVIEWS IMMUNOLOGY (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Intravenous immunoglobulin: Appropriate indications and uses in hematopoietic stem cell transplantation
DR Sokos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Cytomegalovirus pneumonia in adults with leukemia: An emerging problem
Q Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2001)
Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions
K Peggs et al.
BLOOD (2001)
分享论文
